Cohu To Announce Second Quarter 2025 Results on July 31
Get Alerts COHU Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.3%
Revenue Growth %: +16.0%
Join SI Premium – FREE
POWAY, Calif.--(BUSINESS WIRE)-- Cohu, Inc. (NASDAQ: COHU), a global supplier of equipment and services optimizing semiconductor manufacturing yield and productivity, will release financial results for second quarter 2025 on Thursday, July 31, 2025, at 1:00 p.m. Pacific Time/4:00 p.m. Eastern Time.
The Company will host a live conference call and webcast with presentation materials to discuss the results at 1:30 p.m. Pacific Time/4:30 p.m. Eastern Time.
Interested parties may listen live via webcast on Cohu’s investor relations website at https://edge.media-server.com/mmc/p/sb6s4t5r
To participate via telephone and join the call live, please register in advance at https://register-conf.media-server.com/register/BI291f96c3485e46a6bcdb925ba1377e01 to receive the dial-in number along with a unique PIN number that can be used to access the call.
The webcast replay will be available on the Company’s website through July 31, 2026 at www.cohu.com.
About Cohu:
Cohu (NASDAQ: COHU) is a global technology leader supplying test, automation, inspection and metrology products and services to the semiconductor industry. Cohu’s differentiated and broad product portfolio enables optimized yield and productivity, accelerating customers’ manufacturing time-to-market. Additional information can be found at www.cohu.com.
For press releases and other information of interest to investors, please visit Cohu’s website at www.cohu.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250717479147/en/
Cohu, Inc.
Jeffrey D. Jones – Investor Relations
858-848-8106
Source: Cohu, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Momcozy Publishes Baby Carrier vs. Stroller Comparison Guide
- Biotalys Secures Product Registration in California for EVOCA®, Strengthening Regulatory Pathway for Its Lead Asset EVOCA NG
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share